-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Aptiv, Lowers Price Target to $65

Benzinga·08/10/2026 10:23:58
Listen to the news
Barclays analyst Dan Levy maintains Aptiv (NYSE:APTV) with a Overweight and lowers the price target from $73 to $65.